Cargando…
Comparative study on brain pharmacokinetics of Buyang Huanwu Decoction in normal and cerebral ischemia rats using brain microdialysis combined with LC-MS/MS
OBJECTIVE: To conduct a comparative study on the brain pharmacokinetics of seven ingredients (i. e. senkyunolide A, ferulic acid, formononetin, calycosin, ononin, calycosin-O-β-D-glucopyranoside, and paeoniflorin), which were the compounds of Buyang Huanwu Decoction (BHD), in normal and cerebral isc...
Autores principales: | Liu, Wanyi, Zeng, Keqi, Zhou, Xin, Zhang, Yingfeng, Nie, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669359/ https://www.ncbi.nlm.nih.gov/pubmed/36405053 http://dx.doi.org/10.1016/j.chmed.2022.03.007 |
Ejemplares similares
-
Buyang Huanwu Decoction regulates neural stem cell behavior in ischemic brain
por: Liu, Baiyan, et al.
Publicado: (2013) -
Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage
por: Mu, Qingchun, et al.
Publicado: (2014) -
Anti-Inflammatory Effects of Modified Buyang Huanwu Decoction
por: Ryu, Hyang-Hwa, et al.
Publicado: (2020) -
Erythrocyte membrane affinity chromatography, solid-phase extraction and UPLC-QTOF-MS/MS to screen active ingredients of Buyang Huanwu decoction
por: Yu, Aiming, et al.
Publicado: (2019) -
Determination of endogenous sphingolipid content in stroke rats and HT22 cells subjected to oxygen-glucose deprivation by LC‒MS/MS
por: Zeng, Keqi, et al.
Publicado: (2023)